357 related articles for article (PubMed ID: 25331742)
1. Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders.
Tsai SY; Pokrass MJ; Klauer NR; De Credico NE; Su TP
Expert Opin Ther Targets; 2014 Dec; 18(12):1461-76. PubMed ID: 25331742
[TBL] [Abstract][Full Text] [Related]
2. The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.
Penke B; Fulop L; Szucs M; Frecska E
Curr Neuropharmacol; 2018; 16(1):97-116. PubMed ID: 28554311
[TBL] [Abstract][Full Text] [Related]
3. The sigma-1 receptor: roles in neuronal plasticity and disease.
Kourrich S; Su TP; Fujimoto M; Bonci A
Trends Neurosci; 2012 Dec; 35(12):762-71. PubMed ID: 23102998
[TBL] [Abstract][Full Text] [Related]
4. The sigma-1 receptor chaperone as an inter-organelle signaling modulator.
Su TP; Hayashi T; Maurice T; Buch S; Ruoho AE
Trends Pharmacol Sci; 2010 Dec; 31(12):557-66. PubMed ID: 20869780
[TBL] [Abstract][Full Text] [Related]
5. Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases.
Weng TY; Tsai SA; Su TP
J Biomed Sci; 2017 Sep; 24(1):74. PubMed ID: 28917260
[TBL] [Abstract][Full Text] [Related]
6. Role of Sigma-1 Receptor in Cocaine Abuse and Neurodegenerative Disease.
Cai Y; Yang L; Niu F; Liao K; Buch S
Adv Exp Med Biol; 2017; 964():163-175. PubMed ID: 28315271
[TBL] [Abstract][Full Text] [Related]
7. Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.
Hayashi T; Tsai SY; Mori T; Fujimoto M; Su TP
Expert Opin Ther Targets; 2011 May; 15(5):557-77. PubMed ID: 21375464
[TBL] [Abstract][Full Text] [Related]
8. The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration.
Ruscher K; Wieloch T
J Pharmacol Sci; 2015 Jan; 127(1):30-5. PubMed ID: 25704015
[TBL] [Abstract][Full Text] [Related]
9. Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction.
Hayashi T; Fujimoto M
Mol Pharmacol; 2010 Apr; 77(4):517-28. PubMed ID: 20053954
[TBL] [Abstract][Full Text] [Related]
10. At the Crossing of ER Stress and MAMs: A Key Role of Sigma-1 Receptor?
Delprat B; Crouzier L; Su TP; Maurice T
Adv Exp Med Biol; 2020; 1131():699-718. PubMed ID: 31646531
[TBL] [Abstract][Full Text] [Related]
11. Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.
Nguyen L; Lucke-Wold BP; Mookerjee S; Kaushal N; Matsumoto RR
Adv Exp Med Biol; 2017; 964():133-152. PubMed ID: 28315269
[TBL] [Abstract][Full Text] [Related]
12. Sigma-1 Receptors Fine-Tune the Neuronal Networks.
Tsai SA; Su TP
Adv Exp Med Biol; 2017; 964():79-83. PubMed ID: 28315266
[TBL] [Abstract][Full Text] [Related]
13. Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor.
Fujimoto M; Hayashi T; Urfer R; Mita S; Su TP
Synapse; 2012 Jul; 66(7):630-9. PubMed ID: 22337473
[TBL] [Abstract][Full Text] [Related]
14. Compromising σ-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-κB/Bcl-2-dependent mechanism: potential relevance to Parkinson's disease.
Mori T; Hayashi T; Su TP
J Pharmacol Exp Ther; 2012 Jun; 341(3):663-71. PubMed ID: 22399814
[TBL] [Abstract][Full Text] [Related]
15. Insights into the Sigma-1 receptor chaperone's cellular functions: a microarray report.
Tsai SY; Rothman RK; Su TP
Synapse; 2012 Jan; 66(1):42-51. PubMed ID: 21905129
[TBL] [Abstract][Full Text] [Related]
16. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.
Hayashi T; Su TP
Cell; 2007 Nov; 131(3):596-610. PubMed ID: 17981125
[TBL] [Abstract][Full Text] [Related]
17. Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases.
Wu NH; Ye Y; Wan BB; Yu YD; Liu C; Chen QJ
Mol Neurobiol; 2021 Nov; 58(11):5649-5666. PubMed ID: 34383254
[TBL] [Abstract][Full Text] [Related]
18. Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases.
Jia J; Cheng J; Wang C; Zhen X
Front Cell Neurosci; 2018; 12():314. PubMed ID: 30294261
[TBL] [Abstract][Full Text] [Related]
19. Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB.
Meunier J; Hayashi T
J Pharmacol Exp Ther; 2010 Feb; 332(2):388-97. PubMed ID: 19855099
[TBL] [Abstract][Full Text] [Related]
20. Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands.
Bogár F; Fülöp L; Penke B
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
